Skip to content

National childhood and adolescent lymphoma cooperative group (China-Net Childhood Lymphoma, CNCL) multicenter study

National childhood and adolescent lymphoma cooperative group (China-Net Childhood Lymphoma, CNCL) multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020067
Enrollment
Unknown
Registered
2018-12-13
Start date
2017-04-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood and adolescent lymphoma

Interventions

Mature B cell lymphoma group:CNCL-NHL-Mature B cell lymphoma protocol
Lymphoblastic lymphoma group:CNCL-NHL-LBL protocol
Anaplastic large-cell lymphoma group:CNCL-NHL-ALCL protocol
Hodgkin lymphoma group:CNCL-HL protocol

Sponsors

Capital Medical University Beijing Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 16 Years

Inclusion criteria

Inclusion criteria: 1. Aged one month to 16 years old; 2. The patient was diagnosed as one of these pathological subtypes of lymphoma: mature B cell lymphoma ( Burkitts lymphoma, Diffuse largr B cell lymphoma, Follicular lymphoma), lymphoblastic lymphoma, anaplastic large-cell lymphoma, Hodgkin lymphoma; 3. New patients.

Exclusion criteria

Exclusion criteria: 1. The patient has received chemotherapy and/or radiotherapy; 2. The patient with congenital immunodeficiency; 3. Other pathological subtypes of lymphoma not mentioned above.

Design outcomes

Primary

MeasureTime frame
remission state of tumor;remission state of bone marrow;minimal residual disease;overall survival;event-free survival;

Countries

China

Contacts

Public ContactZhang Yonghong

Beijing Children's Hospital, Capital Medical University

yhzhang58@hotmail.com+86 18611755567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026